Evaluating high dose therapy in Multiple Myeloma: use of quality-adjusted survival analysis
about
What is the correct philosophy for the treatment of multiple myeloma?Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategies.Quality-adjusted time without symptoms or toxicity (Q-TWiST): patient-reported outcome or mathematical model? A systematic review in cancer.Renal recovery after severe acute kidney injury in critically ill myeloma patients: a retrospective study.
P2860
Evaluating high dose therapy in Multiple Myeloma: use of quality-adjusted survival analysis
description
im März 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 2002
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2002
@uk
name
Evaluating high dose therapy i ...... ity-adjusted survival analysis
@en
Evaluating high dose therapy i ...... ity-adjusted survival analysis
@nl
type
label
Evaluating high dose therapy i ...... ity-adjusted survival analysis
@en
Evaluating high dose therapy i ...... ity-adjusted survival analysis
@nl
prefLabel
Evaluating high dose therapy i ...... ity-adjusted survival analysis
@en
Evaluating high dose therapy i ...... ity-adjusted survival analysis
@nl
P50
P356
P1476
Evaluating high dose therapy i ...... ity-adjusted survival analysis
@en
P2093
J P Fermand
P2888
P356
10.1023/A:1015096313594
P577
2002-03-01T00:00:00Z
P6179
1028394564